Follow-The-Filings

Holders · period archive

ANTX · An2 Therapeutics Inc.

Q3 2023 13F holders among managers we track latest ownership dossier

Ticker
ANTX
Type
Equity
Class
COM
Total reported value ($000, long equity)
Manager Report date Value Shares